A worldwide assessment of the frequency of suicide, suicide attempts, or psychiatric hospitalization after predictive testing for Huntington disease

American Journal of Human Genetics

Volumn 64, Issue 5, 1999, Pages 1293-1304

  Almqvist, Elisabeth W ^a   Bloch, Maurice ^a,b   Brinkman, Ryan ^a   Craufurd, David ^c   Hayden, Michael R ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b RIVERVIEW HOSPITAL   (Canada)

^c ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ARTICLE; GENE; GENETIC LINKAGE; HOSPITALIZATION; HUMAN; HUNTINGTON CHOREA; PREDICTION; PRIORITY JOURNAL; SUICIDE; SUICIDE ATTEMPT; TRINUCLEOTIDE REPEAT;

EID: 0033358526     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/302374     Document Type: Article

References (49)

1. Almqvist E, Adam S, Bloch M, Fuller A, Welch P, Eisenberg D, Whelan D, et al (1997) Risk reversals in predictive testing for Huntington disease. Am J Hum Genet 61:945-952
2. Babul R, Adam S, Kremer B, Dufrasne S, Wiggins S, Huggins M, Theilmann J, et al (1993) Attitudes toward direct predictive testing for the Huntington disease gene: relevance for other adult-onset disorders. JAMA 270:2321-2325
3. Bloch M, Adam S, Fuller A, Kremer B, Welch JP, Wiggins S, Whyte P, et al (1993) Diagnosis of Huntington disease: a model for the stages of psychological response based on experience of a predictive testing program. Am J Med Genet 47:368-374
4. Bloch M, Adam S, Wiggins S, Huggins M, Hayden MR (1992) Predictive testing for Huntington disease in Canada: the experience of those receiving an increased risk. Am J Med Genet 42:499-507
5. Brandt J, Quaid KA, Folstein SE, Garber P, Maestri NE, Abbott MH, Slavney PR, et al (1989) Presymptomatic diagnosis of delayed-onset disease with linked DNA markers: the experience in Huntington's disease. JAMA 261:3108-3114
6. Bundey S (1997) Few psychological consequences of presymptomatic testing for Huntington disease. Lancet 349:4
7. Codori A-M, Brandt J (1994) Psychological costs and benefits of predictive testing for Huntington's disease. Am J Med Genet 54:174-184
8. Codori A-M, Hansson R, Brandt J (1994) Self-selection in predictive testing for Huntington's disease. Am J Med Genet 54:167-173
9. Codori A-M, Slavney PR, Young C, Miglioretti D, Brandt J (1997) Predictors of psychological adjustment to genetic testing for Huntington's disease. Health Psychol 16:36-50
10. Decruyenaere MM, Evers-Kiebooms G, Boogaerts A, Cassiman J-J, Cloostermans T, Demyttenaere K, Dom R, et al (1995) Predictive testing for Huntington's disease: risk perception, reasons for testing and psychological profile of test applicants. Genet Couns 6:1-13
11. Decruyenaere MM, Evers-Kiebooms G, Boogaerts A, Cassiman J-J, Cloostermans T, Demyttenaere K, Dom R, et al (1996) Prediction of psychological functioning one year after the predictive test for Huntington's disease and impact of the test result on reproductive decision making. J Med Genet 33:737-743
12. Decruyenaere MM, Evers-Kiebooms G, Boogaerts A, Cloostermans T, Cassiman J-J, Demyttenaere K, Dom R, et al (1997) Non-participation in predictive testing for Huntington's disease: individual decision-making, personality and avoidant behaviour in the family. Eur J Hum Genet 5:351-363
13. Di Maio L, Squitieri F, Napolitano G, Campanella G, Trofatter JA, Conneally PM (1993) Suicide risk in Huntington's disease. J Med Genet 30:293-295
14. Farrer LS (1986) Suicide and attempted suicide in Huntington's disease: implications for preclinical testing of persons at risk. Am J Med Genet 24:305-311
15. Fox S, Bloch M, Fahy M, Hayden MR (1989) Predictive testing for Huntington disease. I. Description of a pilot project in British Columbia. Am J Med Genet 32:211-216
16. Hayden MR, Ehrlich R, Parker H, Ferera SJ (1980) Social perspectives in Huntington's chorea. S Afr Med J 58:201-203
17. Health Canada (1994) Suicide in Canada. Update of the report of the task force on suicide in Canada
18. Holloway S, Mennie M, Crosbie A, Smith B, Raeburn S, Dinwoodie D, Wright A, et al (1994) Predictive testing for Huntington disease: social characteristics and knowledge of applicants, attitudes to the test procedure and decisions made after testing. Clin Genet 46:175-180
19. Huggins M, Bloch M, Wiggins S, Adam S, Suchowersky O, Trew M, Klimek ML, et al (1992) Predictive testing for Huntington disease in Canada: adverse effects and unexpected results in those receiving a decreased risk. Am J Med Genet 42:508-515
20. Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72:971-983
21. Kenen RH, Schmidt RM (1978) Stigmatization of carrier status: social implications of heterozygote genetic screening programs. Am J Public Health 68:1116-1120
22. Kessler S (1987) Psychiatric implications of presymptomatic testing for Huntington's disease. Am J Orthopsychiatry 57:212-219
23. Kessler S, Field T, Worth L, Mosbarger H (1987) Attitudes of persons at risk for Huntington disease toward predictive testing. Am J Med Genet 26:259-270
24. Lawson K, Wiggins S, Green T, Adam S, Bloch M, Hayden MR, The Canadian Collaborative Study of Predictive Testing (1996) Adverse psychological events occurring in the first year after predictive testing for Huntington's disease. J Med Genet 33:856-862
25. Marsden CD (1981) Prediction of Huntington's disease. Ann Neurol 10:203-204
26. Mastromauro C, Myers RH, Berkman B (1987) Attitudes toward presymptomatic testing in Huntington disease. Am J Med Genet 26:271-282
27. Mattsson B, Winnberg Almqvist E (1991) Attitudes towards predictive testing in Huntington's disease - a deep interview study in Sweden. Fam Pract 8:23-27
28. Meissen GJ, Myers RH, Mastromauro CA, Koroshetz WJ, Klinger KW, Farrer LA, Watkins PA, et al (1988) Predictive testing for Huntington's disease with use of a linked DNA marker. N Engl J Med 318:535-542
29. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, et al (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-71
30. Nance MA, Leroy BS, Orr HT, Parker T, Rich SS, Heston LL (1991) Protocol for genetic testing in Huntington disease: three years of experience in Minnesota. Am J Med Genet 40:518-522
31. National Institutes of Health (1977) Report of the work group on genetic linkage. Vol 3, pt 1: Commission for the control of Huntington's disease and its consequences. US Department of Health, Education, and Welfare, Public Health Service, National Institutes of Health, Bethesda, pp 63-75
32. Nicolaides NC, Papadopoulos N, Liu B, Wei Y-F, Carter KC, Ruben SM, Rosen CA, et al (1994) Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 371:75-79
33. Oliver JE (1970) Huntington's chorea in Northamptonshire. Br J Psychiatry 116:241-253
34. Platt S (1984) Unemployment and suicidal behavior: a review of the literature. Soc Sci Med 12:93-115
35. Quaid KA (1993) Presymptomatic testing for Huntington disease in the United States. Am J Hum Genet 53:785-787
36. Reddy PS, Housman DE (1997) The complex pathology of trinucleotide repeats. Curr Opin Cell Biol 9:364-372
37. Robins Wahlin T-B, Lundin A, Bäckman L, Almqvist E, Haegermark A, Winblad B, Anvret M (1997) Reactions to predictive testing in Huntington disease: case reports of coping with a new genetic status. Am J Med Genet 73:356-365
38. Rosenfeld A (1984) At risk for Huntington's disease: who should know what and when? Hastings Cent Rep 14:5-8
39. Schoenfeld M, Myers RH, Cupples LA, Berkman B, Sax DS, Clark E (1984) Increased rate of suicide among patients with Huntington's disease. J Neurol Neurosurg Psychiatry 47:1283-1287
40. Simpson SA, Besson J, Alexander D, Allan K, Johnston AW (1992) One hundred requests for predictive testing for Huntington's disease. Clin Genet 41:326-330
41. Sørensen SA, Fenger K (1992) Causes of death in patients with Huntington's disease and in unaffected first degree relatives. J Med Genet 29:911-914
42. Taylor CA, Myers RH (1997) Long-term impact of Huntington disease linkage testing. Am J Med Genet 70:365-370
43. Tibben A, Timman R, Bannink EC, Duivenvoorden HJ (1997) Three-year follow-up after presymptomatic testing for Huntington's disease in tested individuals and partners. Health Psychol 16:20-35
44. Tyler A, Morris M, Lazarou L, Meredith L, Myring J, Harper P (1992) Presymptomatic testing for Huntington's disease in Wales 1987-1990. Br J Psychiatry 161:481-488
45. Wexler NS (1985) Genetic jeopardy and the new clairvoyance. In: Bearn AG, Motulsky AG, Childs B (eds) Progress in medical genetics. Praeger, Philadelphia, pp 278-304
46. Wiggins S, Whyte P, Huggins M, Adam S, Theilmann J, Bloch M, Sheps SB, et al (1992) The psychological consequences of predictive testing for Huntington's disease. N Engl J Med 327:1401-1405
47. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Magnion J, Collins N, et al (1995) Identification of the breast cancer susceptibility gene, BRCA2. Nature 378:789-792
48. World Federation of Neurology, Research Committee, Research Group on Huntington's Chorea (1989) Ethical issues policy statement on Huntington's disease molecular genetics predictive test. J Neurol Sci 94:327-332
49. World Federation of Neurology Research Group on Huntington's Disease, The (1993) Presymptomatic testing for Huntington's disease: a worldwide survey. J Med Genet 30:1020-1022